Press releases

29 Sep 2022

Better, shorter combination treatment for people with visceral leishmaniasis shown to be effective in Eastern Africa

Press releases

5 Sep 2022

Dr Luis Pizarro becomes new Executive Director of the Drugs for Neglected Diseases initiative

Press releases

30 Aug 2022

Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and DNDi to explore joint opportunities to develop affordable and life-saving new drugs for neglected tropical diseases

Press releases

3 Aug 2022

Network of experts calls for urgent boost to research and development of rapid tests for cutaneous leishmaniasis in Latin America

Press releases

27 Jul 2022

Korean cutting-edge technology to reduce the cost of promising drug for neglected disease visceral leishmaniasis

Press releases

6 Jul 2022

Wellcome renews partnership with DNDi to develop new generation drugs to treat leishmaniasis

Press releases

5 Jul 2022

Brazil joins ANTICOV trial to find early treatments for people with mild-to-moderate COVID-19

Press releases

29 Jun 2022

DNDi welcomes new PAHO recommendations for the treatment of leishmaniasis in the Americas

Press releases

14 Jun 2022

Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa

Press releases

8 Jun 2022

New WHO treatment guidelines offer hope for people co-infected with visceral leishmaniasis and HIV

Press releases

1 Jun 2022

Thai partners unite with DNDi to improve access to treatments and diagnostics for people with hepatitis C in Thailand

Press releases

18 May 2022

Consortium formed to discover antivirals for COVID-19 receives NIH funding to develop globally accessible treatments for pandemics

Press releases

29 Apr 2022

Ministry of Health, Malaysia and Drugs for Neglected Diseases initiative combine forces to lead the battle against dengue

Press releases

20 Apr 2022

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Press releases

8 Apr 2022

Government of the Principality of Monaco supports DNDi to increase access to improved treatment for children with HIV

Press releases

15 Mar 2022

Pfizer blocking research to generate evidence on optimal use of novel antiviral for COVID-19 patients in low- and middle-income countries